Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1CNS 1Breast 1

Conditions

Liver Cirrhosis 1Carcinoma, Pancreatic Ductal 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Urination × Gastrointestinal × Clear all
NCT07119957 2025-08-13

ProspEXPO

University Hospital, Angers

Phase NA Not yet recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT02817308 2018-08-31

Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas

Rambam Health Care Campus

Phase NA Unknown
100 enrolled
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡